Skip to main content
Log in

Animal models as an aid to the study and therapy of described leukodystrophies and other white matter disorders

  • Session I
  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Chapman V. M., Miller D. R., Armstrong D., and Caskey C. T. (1989) Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. Proc. Natl. Acad. Sci. USA 86, 1292–1296.

    Article  PubMed  CAS  Google Scholar 

  • The Dutch-Belgian Fragile X Consortium (1994) Fmr1 knockout mice: A model to study Fragile X mental retardation. Cell 78, 23–33.

    Google Scholar 

  • Gurney M. E., Puo H., Chin A. Y., Dal Canto M. C., Polchov C. Y., Alexander D. D., et al. (1996) Major neuron degeneration in mice that express a human Cu, Zn Superoxide Dismutase mutation. Science 264, 1772–1775.

    Article  Google Scholar 

  • Mangiarini L., Sathasivum K., Sellar M., Cozens B., Harper A., Hetherington C., et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493–506.

    Article  PubMed  CAS  Google Scholar 

  • Sakai N., Inui K., Tatsumi N., Fukushima H., Nishigaki T., Taniike M., et al. (1996) Molecular cloning and expression of cDNA for murine galactocerebrosidase and mutation analysis of the twitcher mouse, a model of Krabbe’s disease. J. Neurochem. 66, 1118–1124.

    Article  PubMed  CAS  Google Scholar 

References

  • Conzelmann E. and Sandhoff K. (1983) Partial enzyme deficiencies; residual activities and the development of neurological disorders. Dev. Neurosci. 6, 75–71.

    Google Scholar 

  • Linekugel P., Michel S., Conzelmann E., and Sandhoff K. (1992) Quantitative correlation between the residual activity of β-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum. Genet. 88, 513–523.

    Google Scholar 

Additional References

  • Miyataka T. and Suzuki, K. (1972) Globoid cell leukodystrophy: Additional deficiency of psychosine galactosidase. Biochem. Biophys. Res. Commun. 48, 538–543.

    Article  Google Scholar 

  • Suzuki K. and Suzuki K. (1995). The twitcher mouse: A model for Krabbe disease and for experimental therapies. Brain Pathol. 5, 249–258.

    PubMed  CAS  Google Scholar 

Psychosine Hypothesis

  • Kobayashi T., Yamanaka T., Jacobs J. M., Teixeira F., and Suzuki K. (1980) The twitcher mouse: An enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease). Brain Res. 202, 479–483.

    Article  PubMed  CAS  Google Scholar 

  • Suzuki K. (1998) Twenty-five years of the psychosine hypothesis: A personal perspective of its history and present status. Neurochem. Res. in press.

References

  • Chen Y. Q., Rafi M. A., and Wenger D. A. (1993) Cloning and expression of DNA encoding human galactocerebrosidase, the enzyme deficient in globoid cell leukodystrophy. Hum. Mol. Genet. 2, 1841–1845.

    Article  PubMed  CAS  Google Scholar 

  • Victoria T., Rafi M. A., and Wenger D. A. (1996) Cloning of the canine GALC cDNA and identification of the mutation causing GLD in West Highland White and Cairn Terriers. Genomics 33, 457–462.

    Article  PubMed  CAS  Google Scholar 

  • Luzi P., Rafi A. M., Victoria T., Baskin G. B., and Wenger D. A. (1997) Characterization of the rhesus monkey GAL-cDNA and identification of the mutation causing GLD (Krabbe disease) in this primate. Genomics 42, 319–324.

    Article  PubMed  CAS  Google Scholar 

References

  • Lazarow P. B. and Moser H. W. (1994) Disorders of peroxisome biogenesis, in The Metabolic and Molecular Basis of Inherited Disease (Scriver C R., Bean A. L., Sly W. S., and Valle D., eds.), McGraw Hill, New York, pp. 2287–2324.

    Google Scholar 

  • Moser A. B., Rasmussen M., and Naidu S. (1995) Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. J. Pediatr. 127, 13–22.

    Article  PubMed  CAS  Google Scholar 

Reference

  • Hess B., Saftig P., Hartman D., Coenen R., Lullmann-Rauch R., Goebel H. H., et al. (1996) Phenotype of arylsulfatase A-deficient mice: Relationship to human metachromatic leukodystrophy Proc. Natl. Acad. Sci. USA 93, 14,821–14,826.

    CAS  Google Scholar 

Reference

  • Kobayashi T., Shinnoh N., Kondo A., and Yameda T. (1997) Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem. Biophys. Res. Commun. 232, 631–636.

    Article  PubMed  CAS  Google Scholar 

References

  • Brandon E. P., Idzerda R. L., and McKnight G. S. (1995). Knockouts. Targeting the mouse genomie: a compendium of knockouts (Part 1). Curr. Biol. 5, 625–634.

    Article  PubMed  CAS  Google Scholar 

  • Kennedy M., Rowland S., Miller A., Morris C., Neville L., Dodd A., et al. (1996). Structure and location of the murine adrenoleukodystrophy gene. Genomics 32, 395–400.

    Article  PubMed  CAS  Google Scholar 

  • Kobayashi T., Shinnoh N., Kondo A., and Yamada T. (1997). Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem. Biophys. Res. Commun. 232, 631–636.

    Article  PubMed  CAS  Google Scholar 

  • Mosser J., Douar A., Sarde C., Kioschis P., Feil R., Moser H., et al. (1993). Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361, 726–730.

    Article  PubMed  CAS  Google Scholar 

  • Sarde C.-O., Thomas J., Sadoulet H., Garnier J.-M., and Mandel J.-L. (1994). cDNA sequence of Aldgh, the mouse homolog of the X-linked adrenoleukodystrophy gene. Mammalian Genome 5 810–813.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suzuki, K. Animal models as an aid to the study and therapy of described leukodystrophies and other white matter disorders. J Mol Neurosci 12, 157–164 (1999). https://doi.org/10.1385/JMN:12:3:157

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/JMN:12:3:157

Keywords

Navigation